精选75CNBC 财经（RSS）股市
Abivax获9.2亿美元融资，将独立在美国推出溃疡性结肠炎药物
Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer, CEO tells CNBC
Its latest fundraising round provides the French biotech with enough cash to finance operations through 2029.
更进一步：量化金融体系
看懂新闻只是起点——沿量化金融路径，把它变成能交付的工程能力